BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10925260)

  • 1. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance.
    Schwarz A; Beissert S; Grosse-Heitmeyer K; Gunzer M; Bluestone JA; Grabbe S; Schwarz T
    J Immunol; 2000 Aug; 165(4):1824-31. PubMed ID: 10925260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of dectin-2 in ultraviolet radiation-induced tolerance.
    Aragane Y; Maeda A; Schwarz A; Tezuka T; Ariizumi K; Schwarz T
    J Immunol; 2003 Oct; 171(7):3801-7. PubMed ID: 14500681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
    Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
    J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
    Chiffoleau E; BĂ©riou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells.
    Maeda A; Beissert S; Schwarz T; Schwarz A
    J Immunol; 2008 Mar; 180(5):3065-71. PubMed ID: 18292529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity.
    Schwarz A; Maeda A; Wild MK; Kernebeck K; Gross N; Aragane Y; Beissert S; Vestweber D; Schwarz T
    J Immunol; 2004 Jan; 172(2):1036-43. PubMed ID: 14707077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells.
    Schwarz A; Grabbe S; Mahnke K; Riemann H; Luger TA; Wysocka M; Trinchieri G; Schwarz T
    J Invest Dermatol; 1998 Mar; 110(3):272-6. PubMed ID: 9506448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.
    Sakurai J; Ohata J; Saito K; Miyajima H; Hirano T; Kohsaka T; Enomoto S; Okumura K; Azuma M
    J Immunol; 2000 Jan; 164(2):664-9. PubMed ID: 10623808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
    Vasu C; Prabhakar BS; Holterman MJ
    J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
    Kingsley CI; Karim M; Bushell AR; Wood KJ
    J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration.
    Zhang X; Izikson L; Liu L; Weiner HL
    J Immunol; 2001 Oct; 167(8):4245-53. PubMed ID: 11591746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CTLA-4 in tolerance induction and ttigen administration cell differentiation in experimental autoimmune encephalomyelitis: i. v. antigen administration.
    Ratts RB; Arredondo LR; Bittner P; Perrin PJ; Lovett-Racke AE; Racke MK
    Int Immunol; 1999 Dec; 11(12):1889-96. PubMed ID: 10590254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
    Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
    Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells.
    Kitani A; Chua K; Nakamura K; Strober W
    J Immunol; 2000 Jul; 165(2):691-702. PubMed ID: 10878341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity.
    Jovasevic VM; Gorelik L; Bluestone JA; Mokyr MB
    J Immunol; 2004 Feb; 172(3):1449-54. PubMed ID: 14734721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cells.
    Hwang KW; Sweatt WB; Brown IE; Blank C; Gajewski TF; Bluestone JA; Alegre ML
    J Immunol; 2002 Jul; 169(2):633-7. PubMed ID: 12097362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance.
    Graca L; Thompson S; Lin CY; Adams E; Cobbold SP; Waldmann H
    J Immunol; 2002 Jun; 168(11):5558-65. PubMed ID: 12023351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.